Yeah, it seems like a major mistake to sell this as a one-time purchase. Market it as "genetic monitoring" Charge a monthly or yearly fee to keep getting new genetic insights as research discovers the function of more mutations. Offer upsell re-tests with more complete or accurate sequencing.

I think they must have been banking on the data-set itself being highly valuable and made the tests cheap, then ran out of customers on both ends of the equation.